Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07093606
NA
Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
Sponsor: Sohag University
View on ClinicalTrials.gov
Summary
this study amis to assess the incidence and severity of liver dysfunction in ITP patients receiving eltrombopag.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-07-14
Completion Date
2026-01-20
Last Updated
2025-07-30
Healthy Volunteers
No
Conditions
Interventions
DRUG
Eltrombopag
ITP patients will receive Eltrombopag and evulate occurance of liver disordres .
Locations (1)
Sohag university hospital
Sohag, Egypt